Ren Hong Tang
Director/Miembro de la Junta en SIMCERE PHARMACEUTICAL GROUP LIMITED .
Fortuna: 3 M $ al 31/05/2024
Perfil
Ren Hong Tang is currently an Executive Director at Simcere Pharmaceutical Group Ltd.
and an Executive Director at Jiangsu Simcere Pharmaceutical Co., Ltd.
Previously, he held positions as the Chairman & General Manager at Jiangsu Simcere Medical Diagnostics Co., Ltd., Associate Director-China Innovation Center at AstraZeneca Investment (China) Co. Ltd., Director at 3D Medicines, Inc., and Vice General Manager at Shanghai Shengdi Pharmaceutical Co., Ltd.
He obtained a doctorate degree from Nanyang Technological University in 2007 and an undergraduate degree from Shanghai Jiao Tong University in 2002.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 09/11/2023 | 3 650 000 ( 0.14% ) | 3 M $ | 31/05/2024 |
Cargos activos de Ren Hong Tang
| Empresas | Cargo | Inicio |
|---|---|---|
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Director/Miembro de la Junta | 01/11/2019 |
Jiangsu Simcere Pharmaceutical Co., Ltd.
 Jiangsu Simcere Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1995, Jiangsu Simcere Pharmaceutical Co., Ltd. is a subsidiary of Jiangsu Simcere Medical Diagnostics Co., Ltd. The company is based in Nanjing, China. The Chinese company manufactures and sells pharmaceutical products. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Ren Hong Tang.
| Empresas | Cargo | Fin |
|---|---|---|
| Shanghai Shengdi Pharmaceutical Co., Ltd. | Corporate Officer/Principal | 01/05/2019 |
| AstraZeneca Investment (China) Co. Ltd. | Corporate Officer/Principal | 01/08/2017 |
Jiangsu Simcere Medical Diagnostics Co., Ltd.
 Jiangsu Simcere Medical Diagnostics Co., Ltd. Medical SpecialtiesHealth Technology Jiangsu Simcere Medical Diagnostics Co., Ltd. specializes in premise diagnosis. The company is based in Nanjing, China. and has subsidiaries in China. The Chinese company was founded in 2017. The CEO is Ren Hong Tang. | Director Ejecutivo | - |
| 3D MEDICINES INC. | Director/Miembro de la Junta | - |
Formación de Ren Hong Tang.
| Nanyang Technological University | Doctorate Degree |
| Shanghai Jiao Tong University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Health Technology |
| 3D MEDICINES INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Jiangsu Simcere Pharmaceutical Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1995, Jiangsu Simcere Pharmaceutical Co., Ltd. is a subsidiary of Jiangsu Simcere Medical Diagnostics Co., Ltd. The company is based in Nanjing, China. The Chinese company manufactures and sells pharmaceutical products. | Health Technology |
| AstraZeneca Investment (China) Co. Ltd. | |
| Shanghai Shengdi Pharmaceutical Co., Ltd. | |
Jiangsu Simcere Medical Diagnostics Co., Ltd.
Jiangsu Simcere Medical Diagnostics Co., Ltd. Medical SpecialtiesHealth Technology Jiangsu Simcere Medical Diagnostics Co., Ltd. specializes in premise diagnosis. The company is based in Nanjing, China. and has subsidiaries in China. The Chinese company was founded in 2017. The CEO is Ren Hong Tang. | Health Technology |
- Bolsa de valores
- Insiders
- Ren Hong Tang
